Struggling with labeling complexity in pharma?
You’re not alone. Pharmaceutical and life sciences companies face mounting pressure to meet global regulatory demands, maintain 100% labeling accuracy, and accelerate product launches — all while managing siloed systems and complex stakeholder workflows. Errors aren’t just costly — they’re dangerous. This white paper explores the real risks, challenges, and hidden inefficiencies that stem from outdated Labeling and Artwork Management (LAM) practices.
Discover how Kallik Veraciti transforms labeling for regulated industries
Purpose-built for pharma and medical device manufacturers, Veraciti is a cloud-native platform that centralizes label content, automates artwork generation, and ensures compliance with standards like FDA 21 CFR Part 11 and EU MDR. This paper shows how Kallik’s content-first, AI-enabled approach reduces errors, improves speed-to-market, and offers a true competitive advantage — with a side-by-side comparison against other major LAM solutions.